Literature DB >> 24342716

Tafazzin splice variants and mutations in Barth syndrome.

Susan M Kirwin1, Athena Manolakos2, Sarah Swain Barnett2, Iris L Gonzalez2.   

Abstract

Barth syndrome is caused by mutations in the TAZ (tafazzin) gene on human chromosome Xq28. The human tafazzin gene produces four major mRNA splice variants; two of which have been shown to be functional (TAZ lacking exon 5 and full-length) in complementation studies with yeast and Drosophila. This study characterizes the multiple alternative splice variants of TAZ mRNA and their proportions in blood samples from a cohort of individuals with Barth syndrome (BTHS). Because it has been reported that collection and processing methods can affect the expression of various genes, we tested and chose a stabilizing medium for collecting, shipping and processing of the blood samples of these individuals. In both healthy controls and in BTHS individuals, we found a greater variety of alternatively spliced forms than previously described, with a sizeable proportion of minor splice variants besides the four dominant isoforms. Individuals with certain exonic and intronic splice mutations produce additional mutant mRNAs that could be translated into two or more proteins with different amino acid substitutions in a single individual. A fraction of the minor splice variants is predicted to be non-productive.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  6-carboxyfluorescein, 5-6-FAM™; Alternative splicing; BTHS; Barth syndrome; CE; CL; Cardiolipin; DCM; Dilated cardiomyopathy; EBV; EDTA; Epstein–Barr virus; FAM; FL; HPLC; LVNC; MLCL; NHLBI; National Heart, Lung, and Blood Institute; PCR; PHA; RT; TAZ; Tafazzin; UTR; X-chromosome inactivation; XCI; capillary electrophoresis; cardiolipin; dilated cardiomyopathy; ethylenediaminetetraacetic acid; full length; high performance liquid chromatography; i-AAA protease; intermembrane-AAA protease; left ventricular noncompaction; monolysocardiolipin; phytohemagglutinin; polymerase chain reaction; reverse transcription; untranslated region

Mesh:

Substances:

Year:  2013        PMID: 24342716     DOI: 10.1016/j.ymgme.2013.11.006

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  11 in total

1.  Identification of novel mitochondrial localization signals in human Tafazzin, the cause of the inherited cardiomyopathic disorder Barth syndrome.

Authors:  Ana A Dinca; Wei-Ming Chien; Michael T Chin
Journal:  J Mol Cell Cardiol       Date:  2017-11-10       Impact factor: 5.000

2.  A novel mutation in TAZ causes mitochondrial respiratory chain disorder without cardiomyopathy.

Authors:  Nurun N Borna; Yoshihito Kishita; Kaori Ishikawa; Kazuto Nakada; Jun-Ichi Hayashi; Yoshimi Tokuzawa; Masakazu Kohda; Hiromi Nyuzuki; Yzumi Yamashita-Sugahara; Takashi Nasu; Atsuhito Takeda; Kei Murayama; Akira Ohtake; Yasushi Okazaki
Journal:  J Hum Genet       Date:  2017-01-26       Impact factor: 3.172

Review 3.  The Function of Tafazzin, a Mitochondrial Phospholipid-Lysophospholipid Acyltransferase.

Authors:  Michael Schlame; Yang Xu
Journal:  J Mol Biol       Date:  2020-03-29       Impact factor: 5.469

Review 4.  A critical appraisal of the tafazzin knockdown mouse model of Barth syndrome: what have we learned about pathogenesis and potential treatments?

Authors:  Mindong Ren; Paighton C Miller; Michael Schlame; Colin K L Phoon
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-10-11       Impact factor: 4.733

Review 5.  Barth Syndrome: From Mitochondrial Dysfunctions Associated with Aberrant Production of Reactive Oxygen Species to Pluripotent Stem Cell Studies.

Authors:  Ana Saric; Karine Andreau; Anne-Sophie Armand; Ian M Møller; Patrice X Petit
Journal:  Front Genet       Date:  2016-01-20       Impact factor: 4.599

6.  Tafazzin (TAZ) promotes the tumorigenicity of cervical cancer cells and inhibits apoptosis.

Authors:  Mei Chen; Yuan Zhang; Peng-Sheng Zheng
Journal:  PLoS One       Date:  2017-05-10       Impact factor: 3.240

Review 7.  Role of Tafazzin in Mitochondrial Function, Development and Disease.

Authors:  Michael T Chin; Simon J Conway
Journal:  J Dev Biol       Date:  2020-05-23

Review 8.  Successful management of Barth syndrome: a systematic review highlighting the importance of a flexible and multidisciplinary approach.

Authors:  Stacey Reynolds
Journal:  J Multidiscip Healthc       Date:  2015-07-29

9.  Identification of TAZ mutations in pediatric patients with cardiomyopathy by targeted next-generation sequencing in a Chinese cohort.

Authors:  Jian Wang; Ying Guo; Meirong Huang; Zhen Zhang; Junxue Zhu; Tingliang Liu; Lin Shi; Fen Li; Huimin Huang; Lijun Fu
Journal:  Orphanet J Rare Dis       Date:  2017-02-10       Impact factor: 4.123

10.  New C-Terminal Conserved Regions of Tafazzin, a Catalyst of Cardiolipin Remodeling.

Authors:  Gregory A Shilovsky; Oleg A Zverkov; Alexandr V Seliverstov; Vasily V Ashapkin; Tatyana S Putyatina; Lev I Rubanov; Vassily A Lyubetsky
Journal:  Oxid Med Cell Longev       Date:  2019-10-24       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.